ATF5 and glioblastoma: The overall ATF5 positive rate in GBM samples was 89.80 ± 2.97, while anaplastic, low-grade tumors and nontumorous samples were 86.90 ± 3.72, 29.22 ± 10.95 and 0.40 ± 0.894, respectively.